« Back to Record
Citation APA

Trapnell, B. B., Inoue, Y., Bonella, F., Wang, T., Mc Carthy, C., Arai, T., Akasaka, K., Mariani, F., Mogulkoc, N., Song, J. W., Bondue, B., Jouneau, S., Numakura, T., Öcal, N., Mihaltan, F., Ataya, A., Bendstrup, E., Campo, I., Carey, B., Arena, R., Robinson, B., Fleming, R., Wasfi, Y., Pratt, R., & IMPALA-2 Trial Investigators, (2025). Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis. The New England journal of medicine, 393(8), 764-773. doi:10.1056/NEJMoa2410542


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/394639

Trapnell, B. B., Inoue, Y., Bonella, F., Wang, T., Mc Carthy, C., Arai, T., Akasaka, K., Mariani, F., Mogulkoc, N., Song, J. W., Bondue, B., Jouneau, S., Numakura, T., Öcal, N., Mihaltan, F., Ataya, A., Bendstrup, E., Campo, I., Carey, B., Arena, R., Robinson, B., Fleming, R., Wasfi, Y., Pratt, R., & IMPALA-2 Trial Investigators, (2025). Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis. The New England journal of medicine, 393(8), 764-773. doi:10.1056/NEJMoa2410542